Form 4 for SDEV Stablecoin Development Corp
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-11 · accession 0001437749-23-014704 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-15 | 2023-05-11 | SDEV | Zheng Yenyou | Dir | M - OptEx | — | +858 | 1,716 | +100% | — |
| D | 2023-05-15 | 2023-05-11 | SDEV | Zheng Yenyou | Dir | M - OptEx | $0.00 | -858 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-11 | M | A | 858 | — | 1,716 | D | — | — | (F1) On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares. (F2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. |
| 2 | Derivative | Restricted Stock Units | 2023-05-11 | M | D | 858 | $0.00 | 0 | D | — · — to — | 858 Common Stock | (F1) On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares. (F2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant. |